fda compounding semaglutide warning letter news issues 30 letters to online GLP-1 compounders Out of Shortage, Into Controversy:
Description
Expanding safe treatment options Our findings show that HTG is not a reason to withhold this class of medication from appropriate patients, if they would benefit otherwise, said Iverson
There's a lot of emerging research
doi: 10.1038/nrendo.2010.187 47 UngerRHOrciL
Always consult a qualified healthcare provider before you start, stop, or change any treatment
